GSK Investigational Site

Qingdao 266071

0 studies enrolling now · 3 studies all time

What they study most

Eosinophilic Granulomatosis With Polyangiitis, Nasal Polyps, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) — Running, not enrolling
• Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps — Completed
• Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level — Completed